GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...
WASHINGTON — Pharmaceutical industry giant GSK plans to depart the biotechnology industry’s largest trade group, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback